| 摘要 |
<p>A plasmid comprising a chicken β actin promoter and enhancer; a modified GLP-1 (7-37) cDNA (p(βGLP1), carrying a furin cleavage site, is constructed and delivered into a cell for the expression of active GLP-1. Compositions and method of use thereof to normalize the blood glucose levels of patients with type 2 diabetes are also disclosed.</p> |
